Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders Equity

v3.23.1
Consolidated Statements of Changes in Stockholders Equity - USD ($)
Total
Special Voting Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Series A Preferred Stock [Member]
Series B Preferred Stock [Member]
Balance at Dec. 31, 2020 $ 57,222,620 $ 20,405,219 $ 100 $ 94,088,323 $ (91,497) $ (57,179,525)    
Balance, shares at Dec. 31, 2020   2,667,349 995,062          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of exchangeable shares to common stock   $ (18,039,181) $ 12 18,039,169        
Conversion of exchangeable shares to common stock, shares   (2,358,063) 117,903          
Settlement of convertible notes 11,610,586   $ 15 11,610,571        
Settlement of convertible notes, shares     154,706          
Shares withheld for withholding taxes (520,395)   $ (1) (520,394)        
Shares withheld for withholding taxes, shares     (6,089)          
Shares issued in connection with Viridian acquisition 6,188,000   $ 5 6,187,995        
Shares issued in connection with Viridian acquisition, shares     51,550          
Shares issued in connection with asset purchase 300,000     300,000        
Shares issued in connection with asset purchase, shares     4,167          
Shares issued (returned) in connection with 365 Cannabis acquisition 11,996,061   $ 18 11,996,043        
Shares issued (returned) in connection with 365 Cannabis acquisition, shares     178,572          
Stock-based compensation 2,070,358     2,070,358        
Shares issued in connection with the ATM offering program 1,828,119   $ 3 1,828,116        
Shares issued in connection with the ATM offering program, shares     27,819          
Settlement of liabilities with shares 430,025   $ 1 430,024        
Settlement of liabilities with shares, shares     5,085          
Restricted stock vesting     $ 2 (2)        
Restricted stock vesting, shares     21,386          
Forfeitures of restricted shares, shares     (67)          
Foreign currency translation adjustments 53,020       53,020      
Unrealized gains on convertible notes 100,000       100,000      
Net loss (31,328,711)         (31,328,711)    
Balance at Dec. 31, 2021 59,949,683 $ 2,366,038 $ 155 146,030,203 61,523 (88,508,236)    
Balance, shares at Dec. 31, 2021   309,286 1,550,094          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of exchangeable shares to common stock   $ (180,647)   180,647        
Conversion of exchangeable shares to common stock, shares   (23,614) 1,180          
Settlement of convertible notes 3,925,500   $ 21 3,925,479        
Settlement of convertible notes, shares     207,427          
Shares withheld for withholding taxes (9,926)     (9,926)        
Shares withheld for withholding taxes, shares     (1,662)          
Shares issued (returned) in connection with 365 Cannabis acquisition (940,000)   $ (1) (939,999)        
Shares issued (returned) in connection with 365 Cannabis acquisition, shares     (13,988)          
Common shares and warrants issued in connection with unit offering, net of issue costs 9,178,961   $ 217 9,178,744        
Common shares and warrants issued in connection with unit offering, net of issue costs, shares     2,173,913          
Stock-based compensation 843,693     843,693        
Issuance of convertible redeemable preferred stock, net of issue costs             $ 3,435,600 $ 858,900
Issuance of convertible redeemable preferred stock, net of issue costs, Shares             400,000 100,000
Shares issued in connection with the ATM offering program 1,854,565   $ 64 1,854,501        
Shares issued in connection with the ATM offering program, shares     642,956        
Deemed dividends related to convertible redeemable preferred stock (955,500)     (955,500)     $ 764,400 $ 191,100
Redemption of convertible redeemable preferred stock             $ (4,200,000) $ (1,050,000)
Redemption of convertible redeemable preferred stock, shares             (400,000) (100,000)
Settlement of liabilities with shares 49,529     49,529        
Settlement of liabilities with shares, shares     2,196          
Restricted stock vesting 50,000   $ 2 49,998        
Restricted stock vesting, shares     20,282          
Fractional share adjustment from stock split     $ 2 (2)        
Fractional share adjustment from stock split, shares     20,382          
Foreign currency translation adjustments 40,577       40,577      
Unrealized gains on convertible notes 245,000       245,000      
Net loss (79,057,610)         (79,057,610)    
Balance at Dec. 31, 2022 $ (4,825,528) $ 2,185,391 $ 460 $ 160,207,367 $ 347,100 $ (167,565,846)    
Balance, shares at Dec. 31, 2022   285,672 4,602,780